Influenza Vaccine Market Size, Share, Trends, Growth Outlook

Influenza Vaccine Market is estimated to increase at a growth rate of 7.5% CAGR over the forecast period from 2024 to 2030.

The Influenza Vaccine Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Inactivated, Live Attenuated), By Indication (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospital & Pharmacies, Government & Institutional Supply, Others).

An Introduction to Influenza Vaccine Market in 2024

Amidst the ever-evolving landscape of infectious diseases, the Influenza Vaccine market in 2024 remains a crucial component of public health strategies worldwide. With the recurring threat of seasonal influenza outbreaks and the potential emergence of novel influenza strains, vaccine manufacturers are continually innovating to enhance vaccine efficacy, broaden strain coverage, and improve accessibility. The market is witnessing a surge in demand for quadrivalent and high-dose vaccines, particularly among vulnerable populations such as the elderly and individuals with chronic health conditions. Additionally, advancements in vaccine production technologies, including cell-based and recombinant platforms, are poised to revolutionize influenza vaccine manufacturing and distribution, ensuring preparedness against future influenza pandemics.

Influenza Vaccine Market Trend: Increasing Demand for Quadrivalent and Cell-Based Influenza Vaccines

A prominent trend in the Influenza Vaccine market is the increasing demand for quadrivalent and cell-based influenza vaccines. Quadrivalent vaccines offer protection against four influenza virus strains (two influenza A strains and two influenza B strains), providing broader coverage compared to trivalent vaccines. Additionally, cell-based vaccines, which are produced using cell culture technology instead of traditional egg-based methods, offer advantages such as faster production, reduced risk of egg-related allergic reactions, and potential increased effectiveness in certain populations. As healthcare providers and patients seek more comprehensive and effective influenza vaccination options, the market is witnessing a shift towards the adoption of quadrivalent and cell-based vaccines.

Market Driver: Growing Awareness and Vaccination Campaigns for Influenza Prevention

A key driver fueling the growth of the Influenza Vaccine market is the growing awareness and implementation of influenza vaccination campaigns worldwide. Governments, healthcare organizations, and public health agencies are increasingly emphasizing the importance of annual influenza vaccination as a critical preventive measure to reduce the burden of influenza-related illness, hospitalizations, and deaths. Influenza vaccination campaigns target various demographic groups, including children, older adults, pregnant women, healthcare workers, and individuals with underlying medical conditions, to promote widespread vaccine uptake and coverage. The expansion of vaccination programs, coupled with educational initiatives highlighting the benefits of influenza vaccination in preventing illness and complications, is driving demand for influenza vaccines and supporting market growth.

Influenza Vaccine Market Opportunity: Development of Universal Influenza Vaccines

An opportunity in the Influenza Vaccine market lies in the development of universal influenza vaccines. Current seasonal influenza vaccines require annual updates to match the circulating influenza virus strains, posing challenges in vaccine production, distribution, and effectiveness prediction. Universal influenza vaccines aim to provide long-lasting protection against a broad spectrum of influenza virus strains, including seasonal and pandemic strains, without the need for frequent updates. Research efforts are focused on identifying conserved epitopes or antigens shared among different influenza virus strains to develop universal vaccine candidates. Advancements in vaccine design, adjuvant technologies, and immune response modulation offer potential opportunities to overcome the antigenic variability of influenza viruses and develop more effective universal influenza vaccines, which could revolutionize influenza prevention strategies and address unmet needs in the market. Therefore, investing in the research and development of universal influenza vaccines presents an opportunity to enhance vaccine efficacy, simplify vaccination programs, and contribute to the long-term control of influenza outbreaks.

Influenza Vaccine Market Segmentation

By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Influenza Vaccine Market Companies

AstraZeneca
CSL Ltd
EMERGENT
Emergex Vaccines
GSK plc
Merck & Co. Inc
OSIVAX
Pfizer Inc
SINOVAC
Vaxess Technologies Inc
Viatris Inc

 

 

Reasons to Buy the Influenza Vaccine Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Influenza Vaccine Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Influenza Vaccine Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Influenza Vaccine Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Influenza Vaccine Market Size Outlook, $ Million, 2021 to 2030
3.2 Influenza Vaccine Market Outlook by Type, $ Million, 2021 to 2030
3.3 Influenza Vaccine Market Outlook by Product, $ Million, 2021 to 2030
3.4 Influenza Vaccine Market Outlook by Application, $ Million, 2021 to 2030
3.5 Influenza Vaccine Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Influenza Vaccine Market Industry
4.2 Key Market Trends in Influenza Vaccine Market Industry
4.3 Potential Opportunities in Influenza Vaccine Market Industry
4.4 Key Challenges in Influenza Vaccine Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Influenza Vaccine Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Influenza Vaccine Market Outlook By Segments
7.1 Influenza Vaccine Market Outlook by Segments
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

8 North America Influenza Vaccine Market Analysis And Outlook To 2030
8.1 Introduction to North America Influenza Vaccine Markets in 2024
8.2 North America Influenza Vaccine Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Influenza Vaccine Market size Outlook by Segments, 2021-2030
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

9 Europe Influenza Vaccine Market Analysis And Outlook To 2030
9.1 Introduction to Europe Influenza Vaccine Markets in 2024
9.2 Europe Influenza Vaccine Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Influenza Vaccine Market Size Outlook By Segments, 2021-2030
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

10 Asia Pacific Influenza Vaccine Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Influenza Vaccine Markets in 2024
10.2 Asia Pacific Influenza Vaccine Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Influenza Vaccine Market size Outlook by Segments, 2021-2030
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

11 South America Influenza Vaccine Market Analysis And Outlook To 2030
11.1 Introduction to South America Influenza Vaccine Markets in 2024
11.2 South America Influenza Vaccine Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Influenza Vaccine Market size Outlook by Segments, 2021-2030
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

12 Middle East And Africa Influenza Vaccine Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Influenza Vaccine Markets in 2024
12.2 Middle East and Africa Influenza Vaccine Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Influenza Vaccine Market size Outlook by Segments, 2021-2030
By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AstraZeneca
CSL Ltd
EMERGENT
Emergex Vaccines
GSK plc
Merck & Co. Inc
OSIVAX
Pfizer Inc
SINOVAC
Vaxess Technologies Inc
Viatris Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Inactivated
Live Attenuated
By Indication
Quadrivalent
Trivalent
By Route of Administration
Injection
Nasal Spray
By Age Group
Pediatric
Adult
By Distribution Channel
Hospital & Pharmacies
Government & Institutional Supply
Others